Parasol Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$133K Sell
4,084
-5,281
-56% -$167K 0.22% 36
2016
Q4
$289K Hold
9,365
0.3% 51
2016
Q3
$301K Hold
9,365
0.31% 48
2016
Q2
$313K Sell
9,365
-579
-6% -$18.5K 0.33% 47
2016
Q1
$280K Sell
9,944
-311
-3% -$8.88K 0.27% 43
2015
Q4
$314K Sell
10,255
-1,155
-10% -$36.3K 0.3% 37
2015
Q3
$340K Sell
11,410
-5,238
-31% -$168K 0.31% 40
2015
Q2
$530K Hold
16,648
0.36% 45
2015
Q1
$550K Sell
16,648
-253
-1% -$8.04K 0.35% 45
2014
Q4
$499K Buy
16,901
+970
+6% +$27.8K 0.35% 44
2014
Q3
$447K Sell
15,931
-4,216
-21% -$118K 0.31% 43
2014
Q2
$567K Buy
20,147
+14,213
+240% +$405K 0.39% 34
2014
Q1
$181K Buy
5,934
+527
+10% +$15.7K 0.13% 45
2013
Q4
$157K Buy
+5,407
New +$157K 0.11% 37

Other funds holding PFE

Parasol Investment Management's PFE Position: Q1 2017 in Review

Parasol Investment Management reduced its Pfizer (PFE) stake by 56% in Q1 2017, selling an estimated $167K and leaving 4,084 shares worth $133K. The position accounts for 0.22% of the portfolio, ranked #36.

Parasol Investment Management first reported a position in PFE in Q4 2013 and has held it in 14 quarters since. The position peaked at $567K in Q2 2014. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

  • Parasol Investment Management held 4,084 shares of Pfizer worth $133K as of Q1 2017.
  • Parasol Investment Management sold 5,281 Pfizer shares in Q1 2017, an estimated $167K.
  • Pfizer made up 0.22% of Parasol Investment Management's portfolio in Q1 2017, its #36 holding.
  • Parasol Investment Management first reported a position in Pfizer in Q4 2013 and has held it in 14 quarters since.
  • Parasol Investment Management's Pfizer position peaked at $567K in Q2 2014.
  • 2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Parasol Investment Management's 13F filing for Q1 2017, filed 24 Apr 2017.